1-Boc-1,2,3,6-tetrahydropyridine is used as pharmaceutical intermediate.
Huw M.L.Davies; Joachim Nikolai. Catalytic and enantioselective allylic C-H activation with donor-acceptor-substituted carbenoids. Org. Biomol. Chem. 2005, 3, (23),4176-4187
Rene Nordmann; Patrick Graff; Richard Maurer; Beat H.Gaehwiler. Synthesis and pharmacological evaluation of cis-2,3,3a,4,5,6,7,7a-octahydro-3-oxoisoxazolo[5,4-c]pyridine: a structural analog of the GABA agonist THIP. J. Med. Chem. 1985, 28, (8),1109-1111
Dichiarazioni di rischio (UE): H315-H319-H335
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.
Dichiarazioni precauzionali: P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves and eye/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.